Lewis Hassell to Biomarkers, Tumor
This is a "connection" page, showing publications Lewis Hassell has written about Biomarkers, Tumor.
Connection Strength
1.366
-
Increased expression of melanoma stem cell marker CD271 in metastatic melanoma to the brain. Int J Clin Exp Pathol. 2014; 7(12):8947-51.
Score: 0.388
-
Comparative genomic hybridization in a case of melanoma that loses expression of S100, HMB45, Melan A and tyrosinase in metastasis. Int J Clin Exp Pathol. 2014; 7(1):468-73.
Score: 0.363
-
Malignant transformation of mature cystic teratoma of the ovary. J Obstet Gynaecol Res. 2022 Dec; 48(12):3068-3076.
Score: 0.166
-
Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL. Clin Lymphoma Myeloma Leuk. 2021 07; 21(7):431-438.
Score: 0.150
-
Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis. Tumour Biol. 2017 Oct; 39(10):1010428317713913.
Score: 0.118
-
Melanotic Xp11 translocation renal cancer: report of a case with a unique intratumoral sarcoid-like reaction. Diagn Pathol. 2014 Apr 15; 9:81.
Score: 0.093
-
Micropthalmia transcription factor (MITF) as a diagnostic marker for metastatic melanomas negative for other melanoma markers. Int J Clin Exp Pathol. 2013; 6(8):1658-64.
Score: 0.088